Anebulo Pharmaceuticals Stock Forecast - Simple Regression
| ANEB Stock | USD 0.85 0.01 0.59% |
Anebulo Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Anebulo Pharmaceuticals stock prices and determine the direction of Anebulo Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Anebulo Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
The RSI of Anebulo Pharmaceuticals' share price is below 30 at the present time. This suggests that the stock is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Anebulo Pharmaceuticals, making its price go up or down. Momentum 24
Sell Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (0.13) | EPS Estimate Current Year (0.48) | EPS Estimate Next Year (0.46) | Wall Street Target Price 3 | EPS Estimate Current Quarter (0.12) |
Using Anebulo Pharmaceuticals hype-based prediction, you can estimate the value of Anebulo Pharmaceuticals from the perspective of Anebulo Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of Anebulo Pharmaceuticals on the next trading day is expected to be 0.81 with a mean absolute deviation of 0.21 and the sum of the absolute errors of 13.07. Anebulo Pharmaceuticals after-hype prediction price | USD 0.85 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Anebulo Pharmaceuticals to cross-verify your projections. Anebulo Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Anebulo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Anebulo using various technical indicators. When you analyze Anebulo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Anebulo Pharmaceuticals Simple Regression Price Forecast For the 30th of January
Given 90 days horizon, the Simple Regression forecasted value of Anebulo Pharmaceuticals on the next trading day is expected to be 0.81 with a mean absolute deviation of 0.21, mean absolute percentage error of 0.07, and the sum of the absolute errors of 13.07.Please note that although there have been many attempts to predict Anebulo Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Anebulo Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Anebulo Pharmaceuticals Stock Forecast Pattern
| Backtest Anebulo Pharmaceuticals | Anebulo Pharmaceuticals Price Prediction | Buy or Sell Advice |
Anebulo Pharmaceuticals Forecasted Value
In the context of forecasting Anebulo Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Anebulo Pharmaceuticals' downside and upside margins for the forecasting period are 0.01 and 7.01, respectively. We have considered Anebulo Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Anebulo Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Anebulo Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 115.4332 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.2142 |
| MAPE | Mean absolute percentage error | 0.13 |
| SAE | Sum of the absolute errors | 13.0662 |
Predictive Modules for Anebulo Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Anebulo Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Anebulo Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Anebulo Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Anebulo Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Anebulo Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Anebulo Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Anebulo Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Anebulo Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Anebulo Pharmaceuticals' historical news coverage. Anebulo Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.04 and 7.00, respectively. We have considered Anebulo Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Anebulo Pharmaceuticals is abnormally volatile at this time. Analysis and calculation of next after-hype price of Anebulo Pharmaceuticals is based on 3 months time horizon.
Anebulo Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Anebulo Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Anebulo Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Anebulo Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.66 | 6.20 | 0.27 | 0.07 | 8 Events / Month | 7 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.86 | 0.85 | 0.00 |
|
Anebulo Pharmaceuticals Hype Timeline
Anebulo Pharmaceuticals is presently traded for 0.86. The entity has historical hype elasticity of -0.27, and average elasticity to hype of competition of 0.07. Anebulo is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at -1.66%. %. The volatility of related hype on Anebulo Pharmaceuticals is about 14418.6%, with the expected price after the next announcement by competition of 0.93. About 41.0% of the company shares are held by company insiders. The book value of Anebulo Pharmaceuticals was presently reported as 0.24. The company recorded a loss per share of 0.22. Anebulo Pharmaceuticals had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Historical Fundamental Analysis of Anebulo Pharmaceuticals to cross-verify your projections.Anebulo Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Anebulo Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Anebulo Pharmaceuticals' future price movements. Getting to know how Anebulo Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Anebulo Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TLSA | Tiziana Life Sciences | 0.06 | 7 per month | 0.00 | (0.05) | 7.41 | (5.81) | 21.81 | |
| IMMX | Immix Biopharma | 0.01 | 7 per month | 4.31 | 0.17 | 15.04 | (8.41) | 28.79 | |
| WHWK | Whitehawk Therapeutics | (0.07) | 7 per month | 3.81 | 0.04 | 6.98 | (6.67) | 21.49 | |
| ZNTL | Zentalis Pharmaceuticals Llc | 0.02 | 9 per month | 4.26 | 0.11 | 17.36 | (9.54) | 45.93 | |
| COYA | Coya Therapeutics Common | (0.02) | 4 per month | 0.00 | (0.18) | 4.69 | (5.56) | 18.45 | |
| PLRX | Pliant Therapeutics | (0.03) | 37 per month | 0.00 | (0.14) | 4.58 | (6.71) | 22.72 | |
| CLNN | Clene Inc | 0.43 | 10 per month | 0.00 | (0.07) | 10.11 | (14.19) | 47.42 | |
| MGNX | MacroGenics | 0.03 | 8 per month | 3.80 | (0) | 6.47 | (6.25) | 23.75 | |
| ESLA | Estrella Immunopharma | (0.06) | 5 per month | 0.00 | (0.1) | 12.21 | (15.49) | 50.95 | |
| OKYO | OKYO Pharma Ltd | 0.06 | 19 per month | 5.47 | 0.02 | 10.99 | (8.25) | 34.51 |
Other Forecasting Options for Anebulo Pharmaceuticals
For every potential investor in Anebulo, whether a beginner or expert, Anebulo Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Anebulo Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Anebulo. Basic forecasting techniques help filter out the noise by identifying Anebulo Pharmaceuticals' price trends.Anebulo Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Anebulo Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Anebulo Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Anebulo Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Anebulo Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Anebulo Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Anebulo Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Anebulo Pharmaceuticals stock market strength indicators, traders can identify Anebulo Pharmaceuticals entry and exit signals to maximize returns.
Anebulo Pharmaceuticals Risk Indicators
The analysis of Anebulo Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Anebulo Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting anebulo stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.62 | |||
| Standard Deviation | 5.93 | |||
| Variance | 35.15 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Anebulo Pharmaceuticals
The number of cover stories for Anebulo Pharmaceuticals depends on current market conditions and Anebulo Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Anebulo Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Anebulo Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Anebulo Pharmaceuticals Short Properties
Anebulo Pharmaceuticals' future price predictability will typically decrease when Anebulo Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Anebulo Pharmaceuticals often depends not only on the future outlook of the potential Anebulo Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Anebulo Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 33.8 M | |
| Cash And Short Term Investments | 11.6 M |
Check out Historical Fundamental Analysis of Anebulo Pharmaceuticals to cross-verify your projections. For information on how to trade Anebulo Stock refer to our How to Trade Anebulo Stock guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anebulo Pharmaceuticals. If investors know Anebulo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Anebulo Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Anebulo Pharmaceuticals using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Anebulo Pharmaceuticals' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Anebulo Pharmaceuticals' market price to deviate significantly from intrinsic value.
Understanding that Anebulo Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Anebulo Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Anebulo Pharmaceuticals' market price signifies the transaction level at which participants voluntarily complete trades.